Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Drug Evaluation Div.

Executive Summary

FDA reducing the authorized ceiling of division employees from 38 to 25, effective by Oct. 1, 1986. The division currently has a staff of 44. FDA says reassignment of staff outside the Office of Drug Standards will be done on a voluntary basis. The cuts are related to the increase of staff in the Generic Drugs Div. due to the Waxman/Hatch law. Staff increases in that division have pushed the Office of Drug Standards over employment ceilings.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS009269

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel